Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT06105008 · WITHDRAWN

Trial details

NCT number: NCT06105008
Sponsor: RemeGen Co., Ltd.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2024-12-20
Primary completion: 2025-12-20
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.